<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000269431">
  <TermName>Virulizin</TermName>
  <TermPronunciation>(VEER-yoo-LY-zin)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that activates some types of immune system cells, and is being studied as a treatment for cancer. It belongs to the family of drugs called biological therapy agents.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000731435" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Virulizin&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000731434" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Virulizin&quot;" language="es" id="_4"/>
  <SpanishTermName>Virulizin</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia que activa algunos tipos de células inmunitarias y que está en estudio para el tratamiento del cáncer. Es un tipo de medicamento usado en la terapia biológica.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2002-12-21</DateFirstPublished>
</GlossaryTerm>
